Transgene Biotek Limited (TRABI.BO)

INR 7.34

(-0.53%)

Total Debt Summary of Transgene Biotek Limited

Transgene Biotek Limited's latest annual total debt in 2023 was 140.01 Million INR , up 6.78% from previous year.
Transgene Biotek Limited's latest quarterly total debt in 2023 FY was 140.01 Million INR , up 6.78% from previous quarter.
Transgene Biotek Limited reported annual total debt of 131.12 Million INR in 2022, up 9.2% from previous year.
Transgene Biotek Limited reported annual total debt of 120.07 Million INR in 2021, up 5.98% from previous year.
Transgene Biotek Limited reported quarterly total debt of 135.65 Million INR for 2023 Q2, down 0.0% from previous quarter.
Transgene Biotek Limited reported quarterly total debt of 140.01 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of Transgene Biotek Limited (2023 - 2006)

Historical Annual Total Debt of Transgene Biotek Limited (2023 - 2006)

Year	Total Debt	Total Debt Growth
2023	140.01 Million INR	6.78%
2022	131.12 Million INR	9.2%
2021	120.07 Million INR	5.98%
2020	113.29 Million INR	9.71%
2019	103.26 Million INR	13.08%
2018	91.32 Million INR	-7.28%
2017	98.49 Million INR	-38.46%
2016	160.04 Million INR	7.73%
2015	148.55 Million INR	2.98%
2014	144.25 Million INR	10.47%
2013	130.58 Million INR	-41.86%
2012	224.6 Million INR	8.19%
2011	207.6 Million INR	182.17%
2010	73.57 Million INR	-51.0%
2009	150.13 Million INR	10.69%
2008	135.63 Million INR	-25.16%
2007	181.25 Million INR	37.37%
2006	131.94 Million INR	0.0%

Year	Total Debt	Total Debt Growth
2023 FY	140.01 Million INR	6.78%
2023 Q2	135.65 Million INR	0.0%
2023 Q4	140.01 Million INR	0.0%
2023 Q3	- INR	-100.0%
2023 Q1	- INR	-100.0%
2022 Q4	131.12 Million INR	0.0%
2022 FY	131.12 Million INR	9.2%
2022 Q1	- INR	-100.0%
2022 Q2	125.5 Million INR	0.0%
2022 Q3	- INR	-100.0%
2021 Q4	120.07 Million INR	0.0%
2021 Q2	116.08 Million INR	0.0%
2021 FY	120.07 Million INR	5.98%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2020 FY	113.29 Million INR	9.71%
2020 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2020 Q2	108.56 Million INR	0.0%
2020 Q4	113.29 Million INR	0.0%
2019 Q3	- INR	-100.0%
2019 FY	103.26 Million INR	13.08%
2019 Q2	97.6 Million INR	0.0%
2019 Q4	103.26 Million INR	0.0%
2018 FY	91.32 Million INR	-7.28%
2018 Q1	- INR	0.0%
2018 Q4	91.32 Million INR	0.0%
2017 FY	98.49 Million INR	-38.46%
2016 FY	160.04 Million INR	7.73%
2015 FY	148.55 Million INR	2.98%
2014 FY	144.25 Million INR	10.47%
2013 FY	130.58 Million INR	-41.86%
2012 FY	224.6 Million INR	8.19%
2012 Q1	66.34 Million INR	0.0%
2012 Q2	131.58 Million INR	98.32%
2012 Q4	224.6 Million INR	70.69%
2012 Q3	131.58 Million INR	0.0%
2011 FY	207.6 Million INR	182.17%
2010 FY	73.57 Million INR	-51.0%
2009 FY	150.13 Million INR	10.69%
2008 FY	135.63 Million INR	-25.16%
2007 FY	181.25 Million INR	37.37%
2006 FY	131.94 Million INR	0.0%

Peer Total Debt Comparison of Transgene Biotek Limited

Name	Total Debt	Total Debt Difference
Alfavision Overseas (India) Limited	1.35 Billion INR	89.679%
Biocon Limited	162.76 Billion INR	99.914%
Blue Jet Healthcare Limited	16.12 Million INR	-768.01%
Concord Biotech Limited	97.37 Million INR	-43.783%
Dishman Carbogen Amcis Limited	23.12 Billion INR	99.395%
FERMENTA BIOTECH LIMITED	1.32 Billion INR	89.415%
GENOMIC VALLEY BIOTECH LIMITED	- INR	-Infinity%
Lyka Labs Limited	586.5 Million INR	76.128%
Panacea Biotec Limited	209.9 Million INR	33.297%
SAMSRITA LABS LIMITED	22.03 Million INR	-535.485%
Servoteach Industries Limited	5059.00 INR	-2767442.993%
SMS Lifesciences India Limited	1 Billion INR	86.1%
Supriya Lifescience Limited	54.88 Million INR	-155.12%
Syngene International Limited	5.55 Billion INR	97.478%
TAKE Solutions Limited	370.85 Million INR	62.246%
Titan Biotech Limited	83.02 Million INR	-68.628%
Vanta Bioscience Limited	609.53 Million INR	77.03%